The separation of a mixture of bone marrow stem cells from tumor cells: An essential step for autologous bone marrow transplantation
β Scribed by Philip Rubin; Kenneth T. Wheeler; Peter C. Keng; Philip K. Gregory; Helen Croizat
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 709 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
An autologous bone marrow transplantation (ABMT) was performed in a 45-year-old male patient with AML in therapy-resistant first relapse including CNS-disease. The marrow graft was harvested 18 months before, at the beginning of first remission, and was subjected to an in-vitro incubation with 4-hyd
## Background: The objective of this analysis was to evaluate the role of autologous stem cell transplantation (asct) in prolonging disease free survival (dfs) and overall survival (os) in patients with chronic myeloid leukemia (cml) who received autografts of philadelphia chromosome (ph) positive
We evaluated the AS104 cell separator (Fresenius AG, Bad Homburg, Germany) for ex vivo processing of bone marrow (BM) grafts of 43 patients suffering from germ cell cancer (GCC, n = 22), acute lymphocytic leukemia (ALL, n = 13) and malignant lymphoma (ML, n = 8). Recoveries of total nucleated cells